Malignant PEComa
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa (NCT02494570) | Aadi Bioscience, Inc. | 2015-10-01 |
Track Malignant PEComa automatically
Every clearance here is in the API, with alerts when new ones post.